Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kazia Therapeutics Ltd
KZIA
Healthcare
Biotechnology
Kazia Therapeutics Limited is an oncology-focused drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an investigational brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. It is also developing EVT801, a small-molecule inhibitor...
of VEGFR3, which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. It designed paxalisib to inhibit PI3K, a critical control mechanism in growth and cell division, which is activated in many forms of cancer. The Company’s drug candidates are designed to treat diseases, such as brain cancer, renal cancer, and liver cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:KZIA)
New Post
View:
Posts & Comments
Threaded Posts
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jul 09, 2025 9:07am
Buy buddy buy.
Otherwise it is FOMO for you fellas out there today anyway
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 11, 2025 8:56am
Buy buddy buy because it's taking off this morning.
Otherwise you guys out there will be missing out on this stock today
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 09, 2022 7:00am
New Press Release - KAZIA TO PRESENT PAXALISIB DATA IN ADULT AND PEDIATRIC BRAIN CANCER AT SOCIETY FOR NEURO-ONCOLOGY ANNUAL MEETING
SYDNEY, Nov. 9, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today announced that final data from its phase II study of paxalisib in patients with newly diagnosed glioblastoma will be the subject of an oral presentation at...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 02, 2022 7:15am
New Press Release - Kazia Therapeutics (KZIA): Q123 Cash Flows in Line with Our Estimates
LONDON, UK / ACCESSWIRE / November 2, 2022 / Kazia Therapeutics' Q123 cash flow report provided an update on the company's financial position and business progress. While the quarter was dominated by lead asset paxalisib hitting a roadblock (failing to graduate to stage two of the GBM AGILE study...
read article.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 28, 2022 2:46pm
KZIA .... I will be pi$$ed if this runs
Grrrrrrrrr
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 28, 2022 12:37pm
KZIA ....Looks like the MM that shorted the cr8p out of this
yesterday ....is slowly picking away Me ...no position Cheers !
(476)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 27, 2022 12:11pm
RE:KZIA ...This would have to bust thru ~ $1.03 for me to.....
I forgot to mention that the volume would have to increase dramatically also !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 27, 2022 12:09pm
KZIA ...This would have to bust thru ~ $1.03 for me to.....
increase my position ; ) Just leting u know Cheers !
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 27, 2022 10:42am
KZIA .....I was just going over the LT Chart
This certainly has a propensity to trade big volumes in the past There has to be a reason for this volume.... I'm going to take a small position here sub -$1.00 For my buddy Justin..... Justin
...more
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 27, 2022 10:34am
KZIA ..Wow...That is an exercise in How to Fack Everyone!
You see this on NASDAQ all the time Green to red moves on volume Feel for the chasers
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 27, 2022 9:30am
KZIA ....up in early a.m trading
on watch
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine